Biosimilars growth props up Biocon Q2 PAT by 168% to Rs 126 crore
Biologics major Bengaluru-based Biocon posted a 168 per cent year-on-year rise in its consolidated net profit for the September
Continue readingThe Number One Finance & Business Blog!
Biologics major Bengaluru-based Biocon posted a 168 per cent year-on-year rise in its consolidated net profit for the September
Continue reading